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Studies of the pathogenesis of adenovirus respiratory disease are limited by the strict species-specificity of the adenoviruses. Following
intranasal inoculation of adult C57BL/6 mice with mouse adenovirus type 1 (MAV-1), we detected MAV-1 early region 3 (E3) and hexon
gene expression in the lungs at 7 days post-infection (dpi). We detected MAV-1 E3 protein in the respiratory epithelium at 7 dpi. We did not
detect viral mRNA or protein at 14 dpi, but MAV-1 DNAwas detected by PCR at 21 dpi. Chemokine transcript levels increased between 7
and 14 dpi in the lungs of infected mice. MAV-1 infection induced a patchy cellular infiltrate in lungs at 7 and 14 dpi. This is the first report
demonstrating the presence of MAV-1 in the respiratory epithelium of infected mice and describing chemokine responses in the lung induced
by MAV-1 respiratory infection. MAV-1 infection of mice has the potential to serve as a model for inflammatory changes seen in human
adenovirus respiratory disease.
D 2005 Elsevier Inc. All rights reserved.Keywords: Adenovirus; Chemokine; Lung; InflammationIntroduction
Human adenoviruses cause a wide range of upper and
lower respiratory tract infections in children (Carballal et al.,
2002; Edwards et al., 1985; Larranaga et al., 2000; Pacini et
al., 1987). Adenoviruses are also a common cause of upper
respiratory tract infection and pneumonia in military recruits
(Huebner et al., 1958; Kolavic-Gray et al., 2002; Mogabgab,
1968). Immunocompromised patients experience greater
problems due to adenovirus infections, including more
aggressive respiratory infections, transplant loss and death
(Kojaoghlanian et al., 2003). A potential long-term con-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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risk for the development of asthma and chronic obstructive
pulmonary disease (COPD) (Hogg, 1999, 2001). Human
adenoviruses are also significant as vectors for in vitro and
in vivo delivery of genes into mammalian cells (reviewed in
Kay et al., 2001).
Chemokines are chemotactic cytokines that serve as
chemoattractants for cells involved in the inflammatory
response to stimuli such as infection (Luster, 1998; Rollins,
1997; Taub, 1996). Combined in vitro, ex vivo and in vivo
data suggest that both intact (Alcorn et al., 2001; Booth et
al., 2004; Harrod et al., 1998; Kajon et al., 2003; Leland
Booth and Metcalf, 1999; Otake et al., 1998) and
replication-deficient (Amin et al., 1995; Kodama et al.,
2001; Noah et al., 1996; Schwarz et al., 1999) human
adenoviruses are capable of inducing chemokine responses
in human, murine and bovine lung. Chemokines potentially05) 245 – 254
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(Blease et al., 2000; Lukacs, 2001) and COPD (Beeh et al.,
2003; Qiu et al., 2003; Saetta et al., 2002; Traves et al.,
2002). Chemokine responses to adenovirus vectors contrib-
ute to difficulties encountered with limited persistence of the
vector in its host, low levels of expression of desired genes
and potential morbidity associated with use of the vector
(reviewed in Liu and Muruve, 2003).
A variety of models have been used to study chemokine
responses to adenovirus infection. In vitro systems have
used infection of cell lines with adenovirus or transduction
with adenovirus vectors (Alcorn et al., 2001; Kodama et al.,
2001; Leland Booth and Metcalf, 1999; Schwarz et al.,
1999). An ex vivo lung slice model has been used to
examine chemokine responses to adenovirus infection in the
context of a relevant tissue (Booth et al., 2004). The
majority of these studies have focused on upregulation of
interleukin 8 (IL-8), a CXC chemokine that serves as a
major neutrophil chemoattractant and activator (Baggiolini
et al., 1994). Relatively few studies have used in vivo
animal models to examine chemokine responses to respira-
tory infection with human adenovirus (Harrod et al., 1998;
Kajon et al., 2003). In vivo studies of human adenovirus
pathogenesis are limited by the strict species-specificities of
the adenoviruses. Because exposure of mice to human
adenovirus does not result in a fully permissive infection
(Ginsberg et al., 1991; Kajon et al., 2003), this system does
not allow for a complete assessment of host inflammatory
responses to persistent adenovirus infection. Human adeno-
virus infection of cotton rats (Sigmodon hispidus) has
shown the most promise as an animal model of human
adenovirus respiratory disease (Pacini et al., 1984; Prince et
al., 1993), but it depends on infection with a high dose of a
virus that is not fully adapted to the host. This drawback is
particularly relevant in the study of links between adeno-
virus infection and chronic lung disease such as asthma or
COPD, which are more likely to be associated with effects
of persistent rather than acute infection.
Mouse adenovirus type 1 (MAV-1) serves as an excellent
animal model system for studying adenovirus pathogenesis,
providing the means to define viral and host factors
involved in both acute and persistent adenovirus infections
(reviewed in Smith and Spindler, 1999). The MAV-1 virion
is structurally similar to that of human adenoviruses
(Wigand et al., 1977), and its genomic organization is also
similar to that of human adenovirus (Meissner et al., 1997).
With the exception of the early region 3 (E3) gene (Beard et
al., 1990), MAV-1 gene products have sequence similarity to
those of human adenoviruses (Ball et al., 1988, 1989, 1991;
Beard et al., 1990; Cauthen and Spindler, 1996; Kring et al.,
1992; Kring and Spindler, 1990). Of particular interest,
given the potential association between the human adeno-
virus early region 1A (E1A) gene and long-term sequelae of
infection such as COPD (Elliott et al., 1995; Matsuse et al.,
1992), MAV-1 E1A has approximately 40% similarity to
human adenovirus E1A, with the strongest similarity inconserved region 2 (CR2) (Ball et al., 1988). MAV-1 E1A
shares functional roles of human adenovirus E1A, binding
to the mouse cellular proteins, retinoblastoma protein and
pRb-related protein (Fang et al., 2004; Smith et al., 1996),
and transactivating the human adenovirus type 5 E3
promoter (Ball et al., 1988).
Few studies directly address respiratory infection with
MAV-1 or the role of chemokine responses to MAV-1.
Following intraperitoneal (i.p.) MAV-1 inoculation of adult
C57BL/6 mice, increased mRNA levels for the chemokines
IP-10, MCP-1 and TCA-3 are detected in the brain between
3 and 4 days post-infection (dpi) (Charles et al., 1999).
MAV-1 organ tropism following intranasal (i.n.) inoculation
of outbred mice is similar to that observed following i.p.
inoculation (Kajon et al., 1998). In each case, virus can be
identified in multiple organs including lung, spleen and
brain (Kajon et al., 1998). Following i.n. inoculation of
newborn BALB/c mice less than 24 h old, peribronchiolar
infiltrates comprised of macrophages, and lymphocytes are
seen 3 dpi (Gottlieb and Villarreal, 2000).
We and others have used mouse models to study the
chemokine responses to respiratory infections with a variety
of viruses, including acute viral infections with respiratory
syncytial virus (Domachowske et al., 2000; Haeberle et al.,
2001; John et al., 2003; Mejias et al., 2004; Miller et al.,
2004; Power et al., 2001; Tekkanat et al., 2002) and
influenza virus (Dawson et al., 2000; Tumpey et al., 2000)
as well as persistent viral infections such as those caused by
murine gammaherpesvirus 68 (Sarawar et al., 2002; Wein-
berg et al., 2002, 2004). In this study, we demonstrate that
respiratory infection is established following i.n. inoculation
of C57BL/6 mice with MAV-1. Respiratory infection with
MAV-1 results in chemokine upregulation and cellular
inflammation in the lung. These data indicate that respira-
tory infection with MAV-1 may serve as a useful model to
study adenovirus respiratory disease.Results
Clinical signs of MAV-1 infection
In order to study MAV-1 respiratory infection, we
inoculated 4- to 6-week-old C57BL/6 mice i.n. with 105
plaque-forming units (PFU) of MAV-1 and carefully
monitored them until 14 dpi. At no time point did mice
infected with MAV-1 exhibit clinical signs suggesting
respiratory distress such as tachypnea or labored respira-
tions. CNS symptoms such as ataxia, hyperreflexia, hyper-
esthesia, paresis and flaccid paralysis were absent in all
infected mice.
Detection of MAV-1 in the lung
Using in situ hybridization, Kajon et al. (1998) demon-
strated the presence of MAV-1 in the lungs of adult outbred
Fig. 2. Localization of MAV-1 in lung. Immunohistochemistry was
performed on paraffin-embedded sections from the lungs of mice infected
i.n. with 105 PFU of MAV-1 or mock-infected with conditioned media.
Polyclonal rabbit antiserum was used to detect MAV-1 E3 protein at 7 and
14 dpi. Staining of mock-infected lungs is shown for comparison. Dark
brown staining indicates virus-specific staining, which is present in
respiratory epithelial cells at 7 dpi. Open arrow indicates virus-specific
staining of vascular endothelial cells at 14 dpi. Scale bar, 100 Am.
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confirm and expand on these findings in the current study
using inbred mice. In three separate experiments (n = 2 to 6
mice per condition at each time point), we harvested total
RNA from lungs of mice at 1, 4, 7 and 14 dpi. We used
ribonuclease protection assay (RPA) to detect the expression
of MAV-1 E3 and hexon genes in the lung at each time
point. We did not detect E3 gene expression at 1 or 4 dpi
(data not shown). We detected E3 gene expression in 4 of 6
mice at 7 dpi (Fig. 1A) but did not detect E3 gene
expression in any mice at 14 dpi. Expression of the late
gene encoding the structural protein, hexon, was also
detected at 7 dpi but not at 14 dpi in the lungs of infected
mice (Fig. 1A). Paralleling these data, we found evidence of
infectious virus in lung homogenates at 7 dpi but not at 14
dpi by plaque assay titration on mouse 3T6 fibroblast
monolayers (data not shown). As expected, we did not
detect E3 or hexon gene expression in the lungs of mock-
infected animals at any time point (Fig. 1A).
MAV-1 has a tropism for endothelial cells in the CNS and
other organs (Charles et al., 1998; Guida et al., 1995; Kajon
et al., 1998; Moore et al., 2003). To determine whether
MAV-1 is capable of infecting respiratory epithelial cells
following i.n. inoculation, we performed immunohisto-
chemistry on paraffin-embedded sections of lungs harvested
at various time points following infection to localize MAV-1
E3 protein. At 7 dpi, virus-specific staining was evident in
respiratory epithelial cells lining the medium and large
airways of the lung (Fig. 2). At 14 dpi, MAV-1-specific
staining was not present in respiratory epithelial cells ofFig. 1. Detection of MAV-1 gene expression and DNA in lung. (A) RNA
was obtained from the lungs of mice infected i.n. with 105 PFU of MAV-1
or mock-infected with conditioned media. RNAwas analyzed using RPA to
detect expression of the MAV-1 E3 and hexon genes and the h-actin and
L32 mouse housekeeping genes. Protected viral probe fragments are shown
from RNA isolated from mouse lungs at 7 and 14 dpi. Lanes 1 to 3 present
data for individual mice from one experiment at 7 dpi, and lanes 4 to 9
present data for individual mice from a separate experiment at 7 and 14 dpi.
(B) DNA was obtained from lungs harvested from infected and mock-
infected mice at 21 dpi. PCR was used to amplify a segment of the MAV-1
E1A gene. h-actin was successfully amplified from every sample as a
control (data not shown).infected lungs, although there was occasional staining of
vascular endothelial cells in the lung (arrow, Fig. 2). No
staining was noted using preimmune rabbit serum as a
primary antibody (data not shown).
Expression of hexon and E3 genes was not detected in
lungs harvested from a separate group of mice at 21 dpi
(data not shown). However, we detected the presence of
MAV-1 DNA in the lungs of 2 of 3 mice at 21 dpi by PCR
(Fig. 1B). Together, these data suggest that i.n. inoculation
with MAV-1 resulted in a productive pulmonary infection in
C57BL/6 mice involving respiratory epithelial cells. Fol-
lowing acute infection, MAV-1 genome persisted in the lung
in the absence of detectable viral gene expression.
Chemokine responses to MAV-1 infection
Chemokine upregulation induced by MAV-1 has been
described in the CNS but not the lung following i.p.
inoculation (Charles et al., 1999). We used RPA to quantify
chemokine gene expression in the lungs of mice infected i.n.
with MAV-1. Data from a representative experiment are
presented in Fig. 3. Prior to infection or at 1 and 4 dpi, we
noted little chemokine expression in the lungs of mice, and
levels of chemokine expression did not differ between
MAV-1-infected and mock-infected mice (data not shown).
In contrast, MAV-1 infection upregulated the expression of
nearly all chemokine genes measured at later time points
relative to mock infection (Fig. 3A). Levels of expression of
IP-10 and Ltn peaked at 7 dpi, while levels of expression of
MIP-1a, MIP-1h and RANTES peaked at 14 dpi. MCP-1
and TCA-3 expression were increased in MAV-1-infected
animals to similar levels at 7 and 14 dpi. No significant
differences in MIP-2 expression between MAV-1-infected
and mock-infected mice were detected at any time point.
Expression of the eotaxin gene was not reliably detected by
Fig. 3. Chemokine responses to MAV-1 in the lung. (A) RPA measurement of chemokine gene expression at the indicated time points in the lungs of mice
infected i.n. with 105 PFU of MAV-1 or mock-infected with conditioned media. Quantified data are presented as percentages of the expression of the L32
housekeeping gene. (B) ELISA measurement of protein levels of the representative CC chemokine RANTES in the lungs of MAV-1-infected and mock-
infected mice. For both RPA and ELISA, data are presented as means T standard deviation of values obtained from three mice at each condition (except mock
infection at 7 dpi, where n = 2) from one representative experiment corresponding to lanes 4 to 9 in Fig. 1. Statistical significance was determined using
Student’s t test (*P < 0.05). Similar results were obtained from a separate independent experiment.
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any time point (data not shown). Similar RPA results were
obtained in separate experiments from infected mice at
identical time points (data not shown).
To verify that altered levels of chemokine gene expres-
sion after infection were reflected in chemokine protein
levels, we measured RANTES protein levels in lung
homogenates at 7 and 14 dpi (Fig. 3B). At 7 dpi, levels of
RANTES protein were not increased in the lungs of infected
compared to mock-infected mice. At 14 dpi, when RANTES
gene expression was dramatically upregulated in the lungs
of infected mice (Fig. 3A), levels of RANTES protein were
also significantly elevated compared to mock-infected mice
(Fig. 3B).
Cellular inflammatory responses to MAV-1 infection in the
lung
Chemokines are chemotactic cytokines that form a
concentration gradient to attract cells involved in the
inflammatory response to pathogens and other stimuli
(Luster, 1998). Based on the chemokine upregulation we
detected in the lungs of infected mice, we predicted that acellular inflammatory response would accompany MAV-1
respiratory infection. To assess cellular inflammation, we
examined hematoxylin and eosin-stained sections of lungs
and brain from MAV-1-infected and mock-infected mice.
No cellular infiltrate was present in the lungs of mock-
infected mice at any time point (Fig. 4A) or in the lungs
of infected mice at 1 and 4 dpi (data not shown). A mild
patchy interstitial pneumonitis was present in lungs of
infected mice at both 7 and 14 dpi (Fig. 4A) that was
characterized by a predominantly mononuclear infiltrate
and thickened alveolar walls. In addition, scattered areas
of hypercellularity were focused around medium and large
airways in the lungs of infected mice at 7 dpi; these areas
consisted predominantly of mononuclear cell infiltrates.
These changes were also seen, though to a lesser extent,
at 14 dpi. Thus, maximum cellular inflammation in the
lung was present at 7 dpi when virus was detected in the
lung by RPA, immunohistochemistry and plaque assay,
and was reduced when virus had been cleared from the
lung at 14 dpi.
In a separate experiment, we used bronchoalveolar
lavage (BAL) to characterize the airway cellular inflamma-
tory response to MAV-1 respiratory infection at 7 dpi, when
Fig. 4. Cellular inflammatory responses to MAV-1 respiratory infection. (A) Hematoxylin and eosin-stained sections of lungs of MAV-1-infected and mock-
infected mice demonstrate a mononuclear cellular infiltrate surrounding airways that is most prominent at 7 dpi and a mild interstitial pneumonitis that is
present at both 7 and 14 dpi. Scale bar, 100 Am. (B) Hematoxylin and eosin-stained cytospins of BAL fluid demonstrate an increased number of neutrophils
(open arrows) in the airways of MAV-1-infected mice at 7 dpi. (C) Neutrophils as a percentage of all cells in bronchoalveolar lavage fluid collected from mock-
infected (n = 3) and MAV-1-infected (n = 5) mice at 7 dpi. Each symbol represents an individual mouse.
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the lungs (Fig. 4B). BAL fluid from mock-infected animals
had a monotonous population of alveolar macrophages.
These cells were also evident in BAL fluid from MAV-1-
infected animals. In addition, BAL fluid from infected
animals contained a variable degree of neutrophils (open
arrow, Fig. 4B), ranging from 1.5% to 28.3% of the total
population of cells (Fig. 4C). In contrast, BAL fluid from
mock-infected animals contained only between 0.3% and
0.5% neutrophils. Only rare leukocytes of other types were
noted in either mock-infected or MAV-1-infected animals,
and their percentages did not differ among groups (data not
shown).Discussion
We demonstrate here that MAV-1 is capable of establish-
ing a respiratory infection in the lungs of C57BL/6 mice and
describe the novel finding that MAV-1 protein is present in
respiratory epithelial cells following i.n. inoculation. We
observed a parallel between viral gene expression and
chemokine upregulation in the lungs. As expected from the
chemokine upregulation we detected, MAV-1 infection in
the lung elicited a cellular inflammatory response that
resulted in an interstitial pneumonitis and foci of inflam-
mation around larger airways.
Previous work from our laboratory showed that MAV-1
DNA could be detected using in situ hybridization in
the lung following both i.n. and i.p. inoculation of NIHSwiss outbred mice with MAV-1, but its distribution was
limited to the vascular endothelium (Kajon et al., 1998).
Here, we found MAV-1 protein in both vascular endothe-
lium and respiratory epithelium following i.n. inoculation
of C57BL/6 mice. Several possibilities may explain the
apparent difference in cell tropism. The lack of detection
of MAV-1 nucleic acid in the earlier report is possibly due
to a lower viral dose, 103 PFU, versus 105 PFU used here.
The higher dose may increase the efficiency of entry into a
cell. Following virus entry, the higher dose may result in
increased viral replication to levels whereby viral protein
is detectable by immunohistochemistry. We believe that a
less likely explanation is that detection of protein in
respiratory epithelial cells using immunohistochemistry
was more sensitive than detection of MAV-1 DNA by in
situ hybridization.
Another possibility explaining the apparent cell tropism
difference between this study and the previous study
(Kajon et al., 1998) is that different mouse strains were
used, C57BL/6 and NIH Swiss outbred mice, respectively.
Differential host susceptibility to MAV-1 infection is seen
among various inbred and outbred mouse strains (Guida et
al., 1995; Kring et al., 1995; Spindler et al., 2001). The
50% lethal dose (LD50) for outbred NIH Swiss outbred
mice is 17 PFU (Kring et al., 1995), much lower than the
LD50 of >10
4.4 PFU for C57BL/6 mice (Spindler et al.,
2001). The underlying basis for these differences in
susceptibility is unknown but is likely to involve mouse
strain-specific differences in immune responses to MAV-1.
For instance, chemokine responses to MAV-1 infection in
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(Charles et al., 1999). It is therefore possible that our
ability to detect MAV-1 in the respiratory epithelium in the
present study and not in our previous study (Kajon et al.,
1998) is based on differing abilities of the two mouse
strains to efficiently prevent or control viral infection in
respiratory epithelial cells.
Histopathologic descriptions of adenovirus respiratory
disease in humans are quite limited and largely include
descriptions of fatal disease and disease in immunocom-
promised individuals (Becroft, 1967, 1971; Chany et al.,
1958; Zahradnik et al., 1980). MAV-1-induced respiratory
disease in C57BL/6 mice appears to share some character-
istics with human disease. The respiratory epithelium
appears to be involved in both cases, although the
significant epithelial damage seem in some human cases
(Becroft, 1967, 1971; Chany et al., 1958) was not
prominent in this study. Histopathologic features of
respiratory disease induced by MAV-1 are also similar in
some ways to those present in the cotton rat model of
human adenovirus type 5 (Prince et al., 1993), including
the presence of viral antigen in respiratory epithelial cells
and a cellular infiltrate of peribronchiolar regions that was
most pronounced at 7 dpi in each case. MAV-1 infection of
C57BL/6 mice resulted in a patchy interstitial pneumonitis
(Fig. 4A); an early intra-alveolar cellular exudate, which
was comprised predominantly of macrophages and poly-
morphonuclear leukocytes in the cotton rat model (Prince et
al., 1993), was present following MAV-1 infection,
although to a lesser extent than in human adenovirus
infection of cotton rats. Although the riboprobe template
used to measure chemokine gene expression in this report
includes fewer CXC than CC chemokines, it is perhaps
notable that MIP-2, a CXC chemokine, was the only
chemokine detected that was not upregulated following
MAV-1 infection. MIP-2 serves as a potent neutrophil
chemoattractant in lung injury (reviewed in Guo and Ward,
2002), and the absence of MIP-2 upregulation in the setting
of MAV-1 respiratory infection in part may explain the less
prominent neutrophil influx into the airways in the present
report.
Adenoviruses are capable of establishing persistent
infections in their hosts (reviewed in Horwitz, 2001).
Persistent adenovirus infection may contribute to chronic
lung disease. The human adenovirus E1A protein is
expressed in airway epithelial cells and type 2 alveolar
cells in human lung tissue (Elliott et al., 1995). Human
adenovirus E1A DNA was detected more often in lung
tissue from patients with COPD than in tissue from control
subjects (Matsuse et al., 1992). Human adenovirus DNA
was isolated more frequently in the lungs of children with
asthma than in healthy children (Marin et al., 2000).
Adenovirus capsid protein was detected in BAL fluid of
children with steroid-resistant asthma but not in children
without persistent asthma (Macek et al., 1994). In a guinea
pig model, persistent human adenovirus infection wasassociated with chronic lung inflammation (Vitalis et al.,
1996), enhanced inflammatory response to cigarette smoke
exposure (Vitalis et al., 1998) and lung destruction follow-
ing chronic cigarette smoke exposure (Meshi et al., 2002).
In addition, persistent adenovirus infection of guinea pigs
modifies steroid responsiveness to ovalbumin-induced
allergic lung disease (Yamada et al., 2000), potentially by
inhibiting AP-1-mediated effects of steroid on the expres-
sion of the chemokines eotaxin and MCP-1 (Yamada et al.,
2002).
Persistent MAV-1 infections have also been documented
(reviewed in Smith and Spindler, 1999). In mice infected
with MAV-1, high titers of virus were found in the urine for
up to 24 months (van der Veen and Mes, 1973) and in the
liver up to 52 dpi (Wigand, 1980). Using PCR amplifica-
tion and in situ hybridization, Smith et al. demonstrated
persistence of viral DNA in the brain, spleen, kidneys and
lymph nodes of NIH Swiss outbred mice for up to 55
weeks following i.p. inoculation of MAV-1 (Smith et al.,
1998). We detected MAV-1 DNA in the lungs of infected
mice at 21 dpi using PCR (Fig. 1B). Using nested PCR to
amplify a portion of the MAV-1 E1A coding sequence, we
have also detected MAV-1 genome in the lungs of infected
BALB/c mice at 44 dpi (data not shown). MAV-1 therefore
has the potential to serve as a powerful tool to study the
role of persistent adenovirus infection in chronic lung
disease.
It is clear from the data presented in this report that i.n.
inoculation of C57BL/6 mice results in an acute respiratory
infection. Given the availability of multiple transgenic and
knockout mouse strains together with mutant MAV-1
deficient in the production of E1A (Smith et al., 1996) or
E3 proteins (Beard and Spindler, 1996; Cauthen et al.,
1999), MAV-1 infection will allow the study of specific
host inflammatory responses and specific viral genes
involved in the pathogenesis of adenovirus-induced respi-
ratory infection.Materials and methods
Viruses, mice and experimental infections
Wild-type MAV-1 was grown and passaged in NIH 3T6
fibroblasts, and titers of viral stocks were determined by
plaque assay on 3T6 cells as previously described (Cauthen
and Spindler, 1999). Four- to six-week-old male C57BL/6
mice were purchased from Harlan and maintained in
microisolator cages. Under light isoflurane anesthesia, mice
were inoculated i.n. with 105 PFU in 20 Al sterile PBS.
Control mice were inoculated i.n. with conditioned media at
an equivalent dilution in PBS. Mice were euthanized at the
indicated time points. Organs were harvested, snap frozen in
a dry ice and ethanol bath and stored at 20 -C until
processed further. All animal work complied with all
relevant federal and institutional policies.
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In a subset of mice, lungs and brain were harvested and
fixed in 10% formalin. Prior to fixation, lungs were gently
inflated with PBS via the trachea to maintain lung
architecture. After fixation, organs were embedded in
paraffin, and 5 Am sections were cut for histopathology
and immunohistochemistry. Sections were stained with
hematoxylin and eosin to evaluate cellular infiltrates. All
sectioning and staining was performed by the University of
Michigan Department of Pathology Histology Research
Laboratory.
Immunohistochemistry
Sections were deparaffinized in Citri-solv (Fisher) and
rehydrated in sequential ethanol baths (100%, 95% and 75%
ethanol for 5 min each) followed by a PBS wash (10 min).
Antigen retrieval was accomplished using sequential washes
in 100 mM Tris–HCl, pH 10, boiling in a microwave oven
(4 washes, 5 min each). Slides were allowed to cool
gradually to room temperature and were then washed twice
in phosphate-buffered saline (PBS). Endogenous peroxidase
activity was quenched with hydrogen peroxide, and slides
were blocked by incubating with horse serum (1:667 in
PBS). MAV-1 protein was detected using aE3-1 antiserum
(Beard and Spindler, 1995) diluted 1:2000 in blocking
buffer. This polyclonal rabbit antiserum was raised against a
GST fusion protein containing the unique amino acid
sequence from the E3 gp11K protein. Rabbit preimmune
serum was used as a negative control. The secondary
antibody was biotinylated anti-rabbit antibody (Vectastain
ABC Kit, Vector Laboratories). Detection was accomplished
using the Peroxidase Substrate Kit (Vector Laboratories)
according to the manufacturer’s instructions. Slides were
counterstained for 5 min with hematoxylin.
Bronchoalveolar lavage
Airspace inflammatory cells were collected by BAL.
Lungs of euthanized animals were lavaged three times with
0.8 ml phosphate-buffered saline. Cells in the BAL fluid
were pelleted by centrifugation, cytospun onto glass slides
and stained with hematoxylin and eosin. Cells from ten
randomly selected high-power fields were counted on each
slide, and the proportion of different leukocyte subtypes
calculated.
Isolation of RNA and DNA
The left lung was homogenized with sterile glass beads
and 1 ml TRIzol Reagent (Gibco-BRL) using a Mini
Beadbeater (Biospec Products). The homogenates were
incubated at room temperature for 10 min, and then 200
Al of chloroform was added to each sample. Following a 3-
min incubation at room temperature, the tubes werecentrifuged at 12,000  g for 15 min at 4 -C. The aqueous
phase was transferred to a new microcentrifuge tube, and
total RNA was precipitated with isopropanol. DNA was
extracted from approximately one-third of the right lung
using the DNeasy Tissue Kit (Quiagen Inc.) according to the
manufacturer’s protocol.
Ribonuclease protection assays
Total RNA was analyzed by RPA to measure viral and
chemokine gene expression as previously described (Roch-
ford et al., 2001; Weinberg et al., 2002). The RPAs are
performed in probe excess, so they give a quantitative
measure of the specific RNAs present. Expression of murine
chemokines was measured using the mCK-5c riboprobe
template (PharMingen). An MAV-1 E3 probe was prepared
from plasmid pZU14 as described (Fang et al., 2004). The
full-length E3 template measured 714 nucleotides (nt), and
the size of the protected fragment was 645 nt. A genomic
MAV-1 hexon probe was prepared from plasmid pHEX as
described (Fang et al., 2004). The full-length hexon
template measured 395 nt, and the size of the protected
fragment was 337 nt. The templates for internal h-actin
(Fang et al., 2004) and L32 (Hobbs et al., 1993) controls
were previously described. Linearized E3 and h-actin
templates were combined in equimolar concentrations for
use in riboprobe syntheses driven by T3 bacteriophage RNA
polymerase. Linearized MAV-1 hexon and L32 templates
combined in equimolar concentrations for use in riboprobe
syntheses were driven by T7 bacteriophage RNA polymer-
ase. All syntheses used [a-32P]UTP (Amersham) as the
labeling nucleotide. Probe bands were visualized by auto-
radiography and were quantified where indicated using the
Storm PhosphorImager and ImageQuant software (Molec-
ular Dynamics).
PCR amplification of MAV-1 E1A
DNA extracted from the lungs of mice was amplified
using PCR to detect the presence of MAV-1 E1A. 80 ng of
DNA was amplified by PCR in a reaction volume of 20 Al
containing 4 Al of 5 GoTaq Reaction Buffer (Promega,
final concentration 1.5 mM MgCl2), 0.5 U GoTaq DNA
polymerase (Promega), 0.2 mM dNTPs and 150 ng each of
E1A-FO1 (5V ATG TCG CGG CTC CTA CG 3V) and E1A-
RE1 (5V CAA CGA ACC ATA AAA AGA CAT CAT 3V).
The PCR amplification was carried out for 35 cycles at an
annealing temperature of 50 -C. Amplified products were
separated on a 1.8% agarose gel, stained with ethidium
bromide and photographed using an Electrophoresis Doc-
umentation and Analysis System (Kodak).
Measurement of chemokine protein
Protein levels of the murine chemokine RANTES were
measured in supernatants from organ homogenates obtained
J.B. Weinberg et al. / Virology 340 (2005) 245–254252as described above. Specific chemokines were quantified
using a standard method of sandwich ELISA as previously
described (Hogaboam et al., 1998; Walley et al., 1997). In
brief, microtiter plates were coated with the appropriate
chemokine capture antibody. Samples were added to wells
for 1 h at 37 -C. Detection and processing were performed
with the appropriate biotinylated polyclonal rabbit anti-
cytokine antibody (3.5 Ag/ml), streptavidin–peroxidase
conjugate (Bio-Rad) and chromogen substrate (Bio-Rad).
Plates were read on an ELISA plate scanner at 492 nm.
Recombinant murine chemokine standard curves were used
to calculate the chemokine concentrations.Acknowledgments
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